Topics

New Agents Abound in Benign Hematologic Disorders

12:13 EDT 8 Jul 2019 | OncLive

Kleber Yotsumoto Fertrin, MD, PhD, provided insight into the new options that have emerged in the treatment landscape of benign hematologic malignancies.

Original Article: New Agents Abound in Benign Hematologic Disorders

NEXT ARTICLE

More From BioPortfolio on "New Agents Abound in Benign Hematologic Disorders"

Quick Search